Publications

5803 Results

Clinical trials in oncology; interdisciplinary statistics: Second Edition

Authors
S Green;J Benedetti;J Crowley
Journal / Conference
Chapman & Hall/CRC, London
Year
2002

Factorial design considerations

Authors
S Green;PY Liu;J O'Sullivan
Journal / Conference
Journal of Clinical Oncology 20(16):3424-3430
Year
2002
Research Committee(s)
Lung
Study Number(s)
SWOG-8300

Partitioning and peeling for constructing prognostic groups

Authors
M LeBlanc;J Jacobson;J Crowley
Journal / Conference
Statistical Methods in Medical Research 11:247-274
Year
2002
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30, SWOG-8624

Analysis of multidrug resistance gene-1 (MDR1) expression and function in adult acute lymphoblastic leukemia (ALL). a Southwest Oncology Group (SWOG) study.

Authors
DH Boldt;H Gundaker;DY Lee;Y Gazitt;SJ Forman
Journal / Conference
Blood 100(11):756a(#2991)
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9400

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol

Authors
MS Tallman;JW Andersen;CA Schiffer;FR Appelbaum;JH Feusner;WG Woods;A Ogden;H Weinstein;L Shepherd;C Willman;CD Bloomfield;JM Rowe;PH Wiernik
Journal / Conference
Blood 100(13):4298-4302
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors

Authors
HS Dunn;DJ Haney;SA Ghanekar;P Stepick-Biek;DB Lewis;HT Maecker
Journal / Conference
The Journal of Infectious Diseases 186:15-22
Year
2002

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy

Authors
U Keilholz;J Weber;JH Finke;DI Gabrilovich;WM Kast;ML Disis;JM Kirkwood;C Scheibenbogen;J Schlom;VC Maino;HK Lyerly;PP Lee;W Storkus;F Marincola;A Worobec;MB Atkins
Journal / Conference
Journal of Immunotherapy 25(2):97-138
Year
2002

Generation of iTAg tetramer binding CD8 T cells using antigen presenting cells derived from PBMC under different culture conditions

Authors
JK Payne;AE Simora;K Kuus-Reichel;JCC Chang
Journal / Conference
Journal of Immunotherapy 25(6):S33
Year
2002

A phase II study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) in patients with relapsed or refractory T-lineage acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL): CALGB study 19801.

Authors
DJ De Angelo;D Yu;RK Dodge;SE Coutre;BS Mitchell;RM Stone;AT Stopeck;RA Larson
Journal / Conference
Blood 100(11):198a(#743)
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
C19801

Time to first progression is the best predictor of survival duration in SWOG standard dose chemotherapy studies

Authors
BGM Durie;J Jacobson;B Barlogie;JJ Crowley
Journal / Conference
Blood 100(11):210a(#790)
Year
2002
Research Committee(s)
Leukemia